Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

23andMe

Explore full profile

Helping people access, understand, and benefit from the human genome

Sunnyvale, United StatesFounded 2006Biotech & Life Sciences
Valuation $150M Market cap · 2026
Revenue $190M Latest reported FY

At a glance

Status
Listed
Founded
2006
Headquarters
Sunnyvale, United States
Listing
Public via SPAC 2021
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Series B and later13 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 548 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 12 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 12 startups shown

Former 23andMe employees who went on to found companies, sorted by Dealroom signal score.

BioptimusEst. 2023
Eric DurandFrance
Signal score93
LevelsEst. 2019
Casey MeansUnited States
Signal score90
Brightside HealthEst. 2017
Brad KittredgeUnited States
Signal score85
Agua BlancaEst. 2021
Pierre-Eric LeiboviciFrance
Signal score84
MainStreetEst. 2019
JTJesse TinsleyUnited States
Signal score81
7 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇺🇸 United States95.3%
🇨🇳 China0.8%
🇧🇩 Bangladesh0.4%
🇧🇷 Brazil0.4%
🇦🇷 Argentina0.4%
Top 5 of 13 shown
Web traffic by country
4.2M monthly visits
across markets
🇺🇸 United States74.2%
🇨🇦 Canada5.5%
🇬🇧 United Kingdom5.1%
🇹🇭 Thailand1.2%
🇦🇪 United Arab Emirates1.1%
Top 5 markets shown

Patents

Estimated portfolio value
$54M

50 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where 23andMe was the backer or acquirer, 2012–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across 23andMe's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where 23andMe deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        23andMe's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about 23andMe on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See 23andMe on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles